Related by context. Frequent words. (Click for all words.) 68 pancreatic adenocarcinoma 67 colorectal carcinoma 67 ovarian breast 66 malignant pleural mesothelioma 65 gastrointestinal stromal tumors 64 breast carcinoma 64 hematopoietic cell 64 carcinoid 64 metastatic liver 63 multiple myeloma MM 63 gastrointestinal stromal tumors GIST 63 Vandetanib 63 Daclizumab 63 neoadjuvant therapy 63 pancreatic neuroendocrine tumors 63 allogeneic stem cell 63 pheochromocytoma 62 Everolimus 62 solid organ transplantation 62 Pancreatic 62 renal tumors 62 neoplastic 62 AA amyloidosis 62 ixabepilone 62 recurrent glioblastoma 62 cholangiocarcinoma 62 malignant transformation 62 angiogenesis inhibitor 62 K ras 61 NSABP 61 neuroendocrine tumors 61 neovascularization 61 murine model 61 cell transplantation 61 refractory chronic lymphocytic 61 Amrubicin 61 colorectal lung 61 IMC #B 61 cells hESCs 61 anti fibrotic 61 TACI Ig 61 breast cancer metastasis 61 paroxysmal nocturnal hemoglobinuria 61 Genasense ® 61 R sorafenib tablets 60 xenograft models 60 CD# + [001] 60 premalignant 60 myeloproliferative disorders 60 testicular cancers 60 xenograft 60 PEG SN# 60 Renal Cell Carcinoma 60 HNSCC 60 Glioma 60 Fibrillex TM 60 Chronic Lymphocytic Leukemia 60 Trastuzumab 60 lung fibrosis 60 metastatic RCC 60 KRAS wild 60 metastatic renal cell carcinoma 60 Golimumab 60 pancreatic NET 60 proteasome inhibitor 60 CMV disease 60 axitinib 59 Metastatic 59 hepatocellular carcinoma HCC 59 renal transplantation 59 FLT3 59 sunitinib malate 59 hepatocellular carcinoma 59 carcinoid tumors 59 immunohistochemical 59 leukemia ALL 59 cervical breast 59 heavily pretreated 59 cytomegalovirus CMV 59 medullary thyroid cancer 59 bone metastasis 59 Eculizumab 59 targeting CD# 59 Idiopathic Pulmonary Fibrosis 59 JAK3 59 parathyroid 59 metastatic castration resistant 59 KRAS mutations 59 SHPT 59 relapsed multiple myeloma 59 HER2 positive metastatic breast 59 hepatocellular cancer 59 Carcinoma 59 anticancer therapy 59 Azedra 59 trabectedin 59 metastatic bone 59 autologous bone marrow 59 metastatic lesions 59 chemoradiotherapy 58 PARP inhibitor